KRAS and neoplasm: We identified a novel gene, regulator of calcineurin 2 (RCAN2), that was found to be downregulated in the tumors in Kras-mutated mouse models, which may inhibit calcineurin enzyme activity in CRC and exhibit tumor suppressor function.